Private Label Tranexamic Acid SPF 50 Face Cream Low MOQ

The minimum order quantity for private label tranexamic acid SPF 50 face cream depends heavily on whether you choose a stock base formula or commission a custom development. For stock or white-label formulas — where the manufacturer already has a validated TXA-plus-SPF base on the shelf — MOQs typically start at 500 units and can sometimes go as low as 300 units with Korean or Taiwanese contract manufacturers who specialize in brightening SPF emulsions. For semi-custom work, where you're adjusting the TXA percentage, adding complementary actives like Niacinamide or Vitamin C derivatives, or changing the texture profile from a fluid emulsion to a rich cream, MOQs usually rise to 1,000–2,500 units. Fully custom development with IP assignment and exclusive INCI ownership generally requires 2,500–5,000 units to justify the formulation investment. Several factors push MOQs lower: accepting standard stock packaging (off-the-shelf 30 ml or 50 ml airless pumps and jars rather than custom-molded containers), keeping the formula close to the manufacturer's existing validated base, targeting a single market rather than simultaneously pursuing FDA OTC and EU cosmetics compliance, and being flexible on fill weight. Factors that push MOQs higher include exotic UV filters not in the manufacturer's standard library, a very high TXA concentration that requires additional stability validation, and custom fragrance or preservative system requests. It's also worth noting that SPF 50 products are regulated as OTC drugs in the US, which means the manufacturer must operate under 21 CFR Part 211 cGMP standards. Smaller manufacturers who hold that certification and still accept low MOQs do exist but are harder to find through cold outreach. Platforms like AJ Cosmo Labs allow you to filter the manufacturer directory by MOQ and by OTC drug compliance capability, so you're not wasting time with labs that can't legally produce your formula for your target market. A common mistake first-time founders make is negotiating the unit price before confirming the regulatory pathway. If you're selling in the US and your manufacturer isn't FDA-registered for OTC drug production, no MOQ is low enough — the product simply can't be legally sold with an SPF claim. Lock in compliance capability first, then negotiate quantity and price. For a 500-unit pilot of a stock TXA SPF 50 cream, expect to pay between $4 and $9 per unit in COGS before packaging, labeling, and freight. That unit cost falls meaningfully at 2,500+ units, typically landing in the $5–$11 range for semi-custom work and $8–$16 for fully custom formula with SPF testing included.

Lead time for private label tranexamic acid SPF 50 face cream ranges from 8 weeks on the fast end — if you're using a manufacturer's existing validated stock formula and standard packaging — to 24 weeks or more for a fully custom formula that requires SPF efficacy testing, accelerated stability testing, and regulatory documentation from scratch. Here is a realistic stage-by-stage breakdown. Weeks 1–2 cover the briefing and contract phase: you finalize your brief, sign an NDA, receive and review the manufacturer's quote, and execute the development agreement. Weeks 2–6 cover formula development or adaptation: for stock formulas this is largely skipped; for semi-custom or custom, the cosmetic chemist tweaks the TXA concentration and UV filter system and produces initial lab batches. Weeks 6–10 cover stability and compatibility testing: accelerated stability testing (AST) at 40°C/75% relative humidity over 4–12 weeks is the minimum; longer real-time stability runs are needed for claims of 24- or 36-month shelf life. SPF photostability testing runs concurrently. Weeks 10–14 cover sample evaluation and sign-off: you receive a signed-off formula sample, evaluate sensory performance and shade, and either approve or request modifications. Each modification cycle adds 2–4 weeks. Weeks 14–18 cover regulatory documentation and label copy review: for FDA OTC compliance this includes Drug Facts panel review, facility registration verification, and NDC labeling; for EU this includes the Product Information File and Safety Assessment. Weeks 18–20+ cover pilot batch production and fill: raw material procurement, batch manufacturing, quality control release testing, and shipment to your 3PL or fulfillment center. The single biggest timeline killer is underestimating stability testing. Many founders try to shortcut AST by accepting a manufacturer's existing data on a similar formula — this works if the formulation is genuinely unchanged, but any TXA concentration shift or UV filter substitution resets the clock. Confirm upfront whether the manufacturer's existing stability data covers your exact formula specification. For founders working across US and EU markets simultaneously, regulatory documentation can extend the process by 4–6 additional weeks because the two regimes require different test methodologies (FDA requires in-vivo SPF testing or an accepted in-vitro bridge; EU follows ISO 24444). AJ Cosmo Labs connects founders with manufacturers who carry dual-market compliance capability, which eliminates the need to source two separate production partners.

The total cost of launching a private label tranexamic acid SPF 50 face cream breaks into five buckets: formula development, stability and SPF testing, packaging, manufacturing (COGS), and regulatory compliance documentation. Understanding each bucket prevents founders from underbudgeting and stalling mid-launch. Formula development costs range from $0 for a stock white-label base (cost is embedded in the per-unit price) to $3,000–$8,000 for semi-custom adaptation to $10,000–$25,000 for fully custom development with IP assignment. Custom development at the high end typically includes multiple iteration rounds, a cosmetic chemist's fee, and internal stability testing costs. Some manufacturers amortize development costs into the per-unit price if you commit to a minimum volume. SPF efficacy testing (in-vivo or in-vitro per ISO 24444 or FDA-accepted methods) costs $2,500–$6,000 per formula variant. Photostability testing adds $1,500–$3,500. Accelerated stability testing at a third-party lab runs $1,200–$2,500 for a 3-month panel. If you need dermatologist patch testing or ophthalmologist testing for eye-area use claims, budget an additional $3,000–$7,000. Packaging costs depend on your chosen component. Standard airless pumps or jars sourced from the manufacturer's existing tooling cost $0.35–$1.20 per unit. Custom-molded containers (your own mold) require a tooling investment of $8,000–$30,000 before per-unit component costs. Custom-printed labels and cartons add $0.15–$0.60 per unit at low volumes. Manufacturing COGS (filled, labeled, finished product before freight) typically range as follows: 500-unit stock formula runs at $4–$9 per unit; 1,000-unit semi-custom runs at $7–$14 per unit; 2,500-unit custom runs at $10–$22 per unit. TXA as a raw material is moderately priced (roughly $30–$60/kg at cosmetic grade), but chemical UV filters like Avobenzone and physical UV filters like micronized Zinc Oxide add meaningful raw material cost compared to a non-SPF brightening cream. Regulatory compliance for US OTC adds $1,500–$5,000 for document preparation and label legal review if you're not doing it in-house. EU Safety Assessment by a qualified person costs €800–€2,500. All in, a founder launching a 1,000-unit private label TXA SPF 50 face cream on a semi-custom basis should budget $20,000–$45,000 for the full first run including testing, packaging, and manufacturing — but not including marketing. A stock-formula 500-unit run can be executed for $8,000–$18,000 if you stay within the manufacturer's existing validated system. AJ Cosmo Labs lets you post your budget range in your brief so manufacturers who pitch you already know your constraints.

Tranexamic acid is chemically stable and relatively compatible with a wide range of brightening, anti-aging, and barrier-support actives, making it an excellent anchor ingredient for multi-functional SPF formulas. However, compatibility must always be verified through stability testing — ingredient interactions at the formulation level don't always follow theoretical chemistry. Actives that pair well and are commonly co-formulated with TXA in SPF emulsions include Niacinamide (Vitamin B3) at 2–5%, which complements TXA's anti-melanin mechanism through a different pathway (inhibiting melanosome transfer) and adds pore-minimizing and barrier-repair benefits. Alpha-Arbutin at 1–2% offers a third brightening pathway through tyrosinase inhibition. Kojic Acid is sometimes included but can introduce yellowing stability issues in SPF emulsions and requires careful antioxidant stabilization. Hyaluronic Acid (multiple molecular weights) and Sodium PCA add humectancy without interacting with the UV filter system. Peptides like Acetyl Hexapeptide-8 (for expression line softening claims) are compatible at typical use levels of 3–5 ppm. Panthenol (Vitamin B5) at 0.5–2% supports barrier repair and is universally compatible. Actives that require caution include L-Ascorbic Acid (pure Vitamin C), which is notoriously unstable in aqueous emulsions and highly photolabile — combining it with UV filters creates significant stability challenges. Stabilized Vitamin C derivatives such as Ascorbyl Glucoside or 3-O-Ethyl Ascorbic Acid are more practical alternatives. AHAs (Glycolic Acid, Lactic Acid) are sometimes requested but can compromise the SPF film if not formulated carefully and may conflict with the FDA OTC monograph if present above pH-altering concentrations. Retinoids are generally not combined with SPF daytime products in the same formula because retinoids are photolabile and are best reserved for nighttime use. Always ask your cosmetic chemist or contract manufacturer to provide stability data specifically for the combination you want — not general ingredient information. A manufacturer listed on AJ Cosmo Labs can advise on which active combinations they've already validated, saving you months of development time. For marketing claims, each active you add creates a potential claims burden. If you claim "reduces hyperpigmentation" you need substantiation data. If you claim SPF 50 you need SPF test data. Layer claims responsibly and confirm with your contract manufacturer which claims their testing can support before finalizing packaging copy.

SPF 50 face creams do not require pre-market approval from the FDA in the United States, but they are regulated as over-the-counter (OTC) drugs under the FDA's OTC Drug Review monograph system, which means they must comply with a specific set of requirements before they can be legally sold with an SPF claim. This is a critical distinction that many first-time founders miss. Under the FDA's OTC Sunscreen Drug monograph (updated by the Sunscreen Innovation Act and subsequent rulemakings), a product claiming SPF protection must include a Drug Facts panel on the label (not just a cosmetic ingredient list), identify its active UV filter ingredients with their approved percentages, include specific directions for use and warnings, be manufactured in an FDA-registered facility operating under cGMP standards (21 CFR Part 211), and have substantiated SPF, broad-spectrum, and water-resistance claims through FDA-accepted test methods. As of the current monograph framework, approved UV filter actives for the US market include Zinc Oxide (up to 25%), Titanium Dioxide (up to 25%), Avobenzone (up to 3%), Octinoxate (up to 7.5%), Octisalate (up to 5%), Octocrylene (up to 10%), Homosalate (up to 15%), and a handful of others. Several UV filters widely used in EU and Asian markets — including Tinosorb M, Tinosorb S, and Mexoryl SX — are not yet approved under the US monograph, which means formulas using those filters cannot be sold with an SPF claim in the US without a new drug application. Transexamic acid itself is not a regulated drug active; it is the UV filters that trigger OTC drug status. TXA is listed in the formula as a cosmetic active (in the inactive ingredients section of the Drug Facts panel or in a separate cosmetic label section depending on how the label is structured). For founders targeting the EU, the regulatory landscape is very different: SPF products are regulated as cosmetics under Regulation 1223/2009, not as drugs. They must undergo a Safety Assessment by a qualified person and comply with Annex VI UV filter restrictions, but there is no pre-market approval or OTC drug monograph. The common first-timer mistake is sourcing a manufacturer that produces cosmetics under 21 CFR Part 700 standards (cosmetics GMP) but is not registered and operating under 21 CFR Part 211 (drug GMP). That manufacturer cannot legally produce your SPF 50 product for US sale. AJ Cosmo Labs lets you filter by OTC drug manufacturing capability upfront so you only engage with compliant partners.

Finding a manufacturer who can deliver a stable, regulatory-compliant tranexamic acid SPF 50 face cream at a low MOQ requires vetting across three dimensions simultaneously: formulation expertise, regulatory compliance infrastructure, and operational capacity for small runs. Most generic contract manufacturer directories don't filter across all three at once, which is why founders often spend 3–6 months in fruitless outreach before finding the right partner. Start with a clear brief before reaching out to anyone. Your brief should specify: target TXA concentration (e.g., 3%), desired SPF rating (50), UV filter preference (physical-only, chemical-only, or hybrid), primary market (US OTC, EU cosmetics, or both), target MOQ and annual volume forecast, fill size and packaging format, finish and texture descriptors (fluid, rich cream, gel-cream, tinted or untinted), and budget range for COGS. A vague "I want a TXA SPF 50 cream" inquiry gets deprioritized by serious manufacturers. When evaluating specific manufacturers, request the following documentation before signing anything: FDA facility registration number (for US OTC), a sample Drug Facts label from a comparable product they've manufactured, accelerated stability test data on their existing TXA or SPF formula, a list of their current active SPF clients (under NDA), SPF test report from an accredited lab, and minimum batch size and setup fee structure. Regional sourcing options include US-based OTC contract manufacturers (strong regulatory compliance, higher COGS, easier communication), Korean and Taiwanese manufacturers with US OTC satellite offices (often lower COGS, excellent formulation heritage in brightening actives, experienced with TXA-SPF systems), and EU-based manufacturers (strong for EU-first launches, less common for US OTC compliance). Red flags to watch for: a manufacturer who says they can produce your formula without asking about your target market's regulatory framework; SPF claims without in-vivo or accredited in-vitro test backing; an MOQ that seems impossibly low (under 200 units) for a custom SPF OTC product — it usually means the formula isn't truly validated; no NDA before sharing formula details. AJ Cosmo Labs was built specifically to solve this vetting problem. The iOS app hosts a curated directory of screened cosmetic manufacturers, allows you to post a detailed project brief and receive competitive quotes, and lets you message suppliers, track sample shipments, and release milestone-based payments — all in one place. Download AJ Cosmo Labs from the App Store, post your TXA SPF 50 brief, and start receiving qualified manufacturer responses much faster than cold outreach.

Stability testing for a tranexamic acid SPF 50 face cream is more extensive than for a non-SPF brightening product because you must validate both the cosmetic emulsion system and the SPF performance over time. Skipping or shortcutting stability testing is the most common reason indie brands face reformulation crises 6–12 months after launch. The core battery of stability tests for this formula type includes accelerated stability testing (AST), SPF photostability testing, compatibility testing, and — for US OTC — efficacy substantiation testing. Accelerated stability testing (AST): samples stored at 40°C/75% relative humidity for 3 months are evaluated at T=0, T=4 weeks, T=8 weeks, and T=12 weeks. Parameters evaluated include appearance (phase separation, color change, sedimentation), odor, pH, viscosity, microbial counts, and active ingredient assay (TXA concentration by HPLC). A 3-month AST at 40°C is generally considered predictive of approximately 24 months at ambient conditions, though real-time stability data must eventually confirm this for regulatory purposes. SPF photostability testing: UV filters — particularly Avobenzone — degrade under UV irradiation, which means the SPF value of the product may fall below the labeled claim after sun exposure. ISO 24444 and FDA test protocols include irradiation steps; your manufacturer or a third-party lab will irradiate samples and confirm SPF persistence. If your formula uses a photostabilizer like Octocrylene or Polysilicone-15, test data must confirm it is effective in your specific formula. Broad-spectrum testing: for a US OTC SPF 50 claim, you must demonstrate that the product meets the critical wavelength (≥370 nm) and UVA/UVB ratio requirements of the FDA Broad Spectrum Test. This is done via in-vitro spectrophotometry. Compatibility testing: the TXA-active should be tested for compatibility with your chosen preservative system, chelating agents, emulsifiers, and UV filters. Interaction between TXA's amine functionality and aldehyde-releasing preservatives (e.g., DMDM Hydantoin) can cause stability or sensory issues and should be ruled out. Freeze-thaw cycling: typically 5 cycles of -10°C to +25°C to simulate shipping and retail temperature variation. Evaluates emulsion integrity and active assay drift. Real-time stability: ideally 6–24 months at 25°C/60% RH, run concurrently with AST. Required for final shelf-life claims and for EU PIF documentation. Budget $5,000–$12,000 for a full stability and SPF testing package at an accredited third-party lab. Some contract manufacturers include a portion of this testing in their development fee. AJ Cosmo Labs manufacturers in the directory can advise on which tests are already complete for their stock formulas, potentially saving you $3,000–$6,000 if you work within an existing validated base.